More Immutep Ltd news Immutep LtdASX: IMM Positive Data from Phase II Trial in Soft Tissue Sarcoma Nov 14, 2024 at 2:55 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
